Answers are grounded in this paper and cite their sources.
The chromanone scaffold is a privileged structure in heterocyclic chemistry and drug discovery. A highly efficient copper-catalyzed asymmetric conjugated reduction of chromones is developed to give chiral chromanones with good yields (80-99%) and excellent ee values (94->99% ee). Particularly noteworthy is that chiral thiochromanones are also constructed using this method in 74-87% yields with 96-97% ee. The established asymmetric synthesis paves the way for their further pharmaceutical studies.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: